2021
DOI: 10.1111/1751-7915.13778
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial fermentation and isotope labelling optimized for amyloidogenic proteins

Abstract: We developed a cost sensitive isotope labelling procedure using a fed-batch fermentation method and tested its efficiency producing the 15 N-, 13 C-and 15 N/ 13 C-labelled variants of an amyloidogenic miniprotein (E5: EEEAVRLYIQWLKEGGPSSGRPPPS). E5 is a surface active protein, which forms amyloids in solution. Here, we confirm, using both PM-IRRAS and AFM measurements, that the air-water interface triggers structural rearrangement and promotes the amyloid formation of E5, and thus it is a suitable test protein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…An additional goal of the project was to create a suitable expression system to produce a biologically active antigen with good yield for testing the neutralizing nanobodies in a fast and accurate way. Although the most convenient method of recombinant protein production is rapid and economical bacterial production [ 28 , 29 ], efficiently expressing the RBD is challenging. The RBD consists of β-sheets and five disulfide bonds stabilizing its structure [ 30 , 31 ].…”
Section: Resultsmentioning
confidence: 99%
“…An additional goal of the project was to create a suitable expression system to produce a biologically active antigen with good yield for testing the neutralizing nanobodies in a fast and accurate way. Although the most convenient method of recombinant protein production is rapid and economical bacterial production [ 28 , 29 ], efficiently expressing the RBD is challenging. The RBD consists of β-sheets and five disulfide bonds stabilizing its structure [ 30 , 31 ].…”
Section: Resultsmentioning
confidence: 99%
“…(Budapest, Hungary). Exendin-4 (or Exenatide) derivative miniprotein (EEEAVRLYIQWLKEGGPSSGRPPPS) (a marketed drug for type-2 diabetes mellitus, E5) was produced by bacterial expression using the previously described protocol [ 57 ]. Specific parameters of the proteins were summarized in Table 5 and Table S1 .…”
Section: Methodsmentioning
confidence: 99%